Kythera Biopharmaceuticals
Kythera develops novel prescription products for esthetic medicine.
Business Model:
Revenue: $1.2M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Kythera Biopharmaceuticals Information
Kythera Biopharmaceuticals was acquired by
Allergan.
The acquisition happend on 2015-06-17.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 27200 Agoura Rd
City: Calabasas
State: CA
Zip: 91301
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$125M
Raised Total:$138M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Kythera develops novel prescription products for esthetic medicine.
Contact Phone:
+18185874500
Contact Email:
Kythera Biopharmaceuticals went public on 10/11/2012 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/11/2012
Ticker Symbol:
KYTH
IPO Price:
$16/share
Amount Raised:
$70M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
